Originally from the Bahamas, Dr. Glass enrolled in the Medical Scientist Training Program at Baylor College of Medicine (BCM) in 1998. He received his PhD from BCM in 2005 from the Department of Human Genetics where he studied the role of Canonical Wnt Signaling in Bone Regulation. He received his MD from BCM in 2006 and compleed his transitional year internship at Cambridge Hospital in Massachusetts in 2008. Dr. Glass completed his residency training in Dermatology and a postdoctoral fellowship in the McDermott Center (with Helen Hobbs) at the University of Texas Southwestern Medical Center.  He is board certified by the American Board of Dermatology.

Dr. Glass' main research interest is in understanding how keloids (exuberant scarring of the skin) occur and in finding the genes that predispose people to develop keloids. Keloids occur disproportionately more often in skin of color, and the ability to develop keloids can be inherited within families. Dr. Glass is compiling a registry of individuals as well as families affected by keloids in order to collect samples and information to study keloids further. His other research interest is identifying genes that cause rare skin disorders. Dr. Glass practices general dermatology and has an interest in genetic skin disorders.


Medical School
Baylor College of Medicine (2006)
Cambridge Hospital (2008), Transitional Year
UT Southwestern Medical Center (2011), Dermatology

Research Interest

  • Dermal Biology
  • Fibroblasts
  • Genetics
  • Keloids


Featured Publications LegendFeatured Publications

Whole exome sequencing.
Glass DA, Nuara AA Dermatitis 2013 Jan 24 1 33-4
Painful toe ulcers.
Sanchez AT, Weaver SP, Glass DA J Fam Pract 2013 Jan 62 1 37-8
Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides.
Sun G, Berthelot C, Li Y, Glass DA, George D, Pandya A, Kurzrock R, Duvic M J. Am. Acad. Dermatol. 2009 Feb 60 2 231-5
Two pediatric cases of Blau syndrome.
Glass DA, Maender J, Metry D Dermatol. Online J. 2009 15 12 5
In vivo analysis of Wnt signaling in bone.
Glass DA, Karsenty G Endocrinology 2007 Jun 148 6 2630-4
Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.
Glass DA, Karsenty G Ann. N. Y. Acad. Sci. 2006 Apr 1068 117-30
Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.
Glass DA, Karsenty G Curr. Top. Dev. Biol. 2006 73 43-84
WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature.
Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, Kurup S, Glass DA, Patel MS, Shu W, Morrisey EE, McMahon AP, Karsenty G, Lang RA Nature 2005 Sep 437 7057 417-21
A new insight into the formation of osteolytic lesions in multiple myeloma.
Glass DA, Patel MS, Karsenty G N. Engl. J. Med. 2003 Dec 349 26 2479-80
Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice.
Levasseur R, Barrios R, Elefteriou F, Glass DA, Lieberman MW, Karsenty G Endocrinology 2003 Jul 144 7 2761-4


Featured Books Legend Featured Books

Honors & Awards

  • Children's Medical Center CCRAC
    Junior Investigator Research Award (2013)
  • Dermatology Foundation
    Career Development Award (2013)
  • UT-Southwestern / Galderma
    Pilot & Feasibility Study Grant (2012)
  • Dermatology Foundation
    Dermatologist Investigator Research Fellowship Award (2011)
  • Skin of Color Society
    AMBI Research Grant (2011)
  • UT-Southwestern Medical Center
    Physcian Scientist Training Program (2010)
  • BCM Outstanding Student Award
    Graduate School (2006)
  • Graduate Student Rep Speaker
    BCM Commencement (2006)
  • Speaker, Gordon Research Conference
    Bones and Teeth (2005)

Professional Associations/Affiliations

  • American Academy of Dermatology
  • Dallas County Medical Society
  • Dermatology Foundation
  • National Medical Association
  • Skin of Color Society
  • Society for Investigative Dermatology
  • Texas Medical Association
  • Women's Dermatologic Society